Literature DB >> 6652024

Screening for colorectal cancer in a factory-based population with Fecatest.

F I Lee.   

Abstract

This report concerns a screening programme for colorectal cancer using Fecatest, a relatively sensitive test for faecal occult blood, in a factor-based population. A total of 2420 workers between 40 and 65 years of age returned kits for testing following suitable dietary restriction. In Factory A, in which screening was offered as part of an annual medical examination, 989 men agreed to participate, a compliance rate of 45%. In Factory B, in which screening was offered in their weekly pay packets, 1431 men participated, a compliance rate of 22%. An overall positivity rate of 5.8% was found, 4.6% in Factory A and 6.6% in Factory B. Five cancers were found, two of the rectum, one at the recto-sigmoid junction, one in the sigmoid colon and one in the transverse colon. Two of these lesions were at Dukes Stage A, one at Stage B and two at Stage C. In addition, 25 adenomatous polyps were found in 17 men. In 13 these were characterized as tubular adenomata and in 4 as tubulovillous adenomata. The mean age at diagnosis in the polyp cases was 52.6 years and in the cancer cases 58.8 years. Increased specificity is obtained by excluding participants below 46 years of age. The detection rate in the 46-65 year range is approximately 1 in 100 for adenomatous polyps and 1 in 300 for cancer in the population screened. This detection rate is higher than most comparable studies using a less sensitive Guaiac test on older populations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652024      PMCID: PMC2011568          DOI: 10.1038/bjc.1983.275

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Genesis of colorectal cancer.

Authors:  B C Morson
Journal:  Clin Gastroenterol       Date:  1976-09

2.  The early detection of colorectal cancer.

Authors:  S F Miller; A R Knight
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Multiphasic checkup evaluation study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years.

Authors:  L G Dales; G D Friedman; S Ramcharan; A B Siegelaub; B A Campbell; R Feldman; M F Collen
Journal:  Prev Med       Date:  1973-06       Impact factor: 4.018

4.  Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer.

Authors:  V A Gilbertsen
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

5.  Occult blood tests and colorectal tumours.

Authors:  A Ribet; J Frexinos; J Escourrou; J Delpu
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

6.  The false-negative hemoccult test.

Authors:  M Fleisher; M K Schwartz; S J Winawer
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

7.  The survival of patients with colorectal cancer treated in a regional hospital.

Authors:  P G Gill; P J Morris
Journal:  Br J Surg       Date:  1978-01       Impact factor: 6.939

8.  Evaluation of Fecatest, a new guaiac test for occult blood in feces.

Authors:  H Adlercreutz; K Liewendahl; P Virkola
Journal:  Clin Chem       Date:  1978-05       Impact factor: 8.327

9.  Outpatient screening for gastrointestinal lesions using guaiac-impregnated slides.

Authors:  G A Glober; S M Peskoe
Journal:  Am J Dig Dis       Date:  1974-05

10.  Feasibility of fecal occult-blood testing for detection of colorectal neoplasia: debits and credits.

Authors:  S J Winawer; D G Miller; D Schottenfeld; S D Leidner; P Sherlock; B Befler; M W Stearns
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

View more
  2 in total

1.  Telephone outreach to increase colorectal cancer screening in an urban minority population.

Authors:  Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

2.  Mailed fecal-immunochemical test for colon cancer screening.

Authors:  Jeanette M Daly; Barcey T Levy; Mary L Merchant; Jason Wilbur
Journal:  J Community Health       Date:  2010-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.